Clinical Trials

A multi-site clinical trial is currently underway in the U.S. and in Israel. Information on the neuroAD study can be found at

To learn more about additional sites in other locations throughout the world, or for more information about participating in a clinical trial, please contact Neuronix at


Currently these centers are participating in the study:


Lou Ruvo Center for Brain Health, Cleveland Clinic, Las Vegas, Nevada, U.S.

Contact person: Yolande Mucharbach

Phone: +1-702-685-7070



Palm Beach Neurology and Premiere Research Institute, West Palm Beach, Florida, U.S.

Contact person: Dr. Teresa Villena

Phone: +1-561-845-0500



Beth Israel Deaconess Medical Center, Boston, Massachusetts, U.S.

Contact person: Avi Fuld

Phone: +1-617-667-0258


Banner Sun Health Research Institute, Sun City, Arizona, U.S.

Contact person: Carolyn Liebsack

Phone: +1-623-832-6514



NYU Langone Medical Center, New York, New York, U.S.

Contact person: Christina Michel

Phone: +1-212-263-5708



Cleveland Clinic, Cleveland, Ohio, US

Contact person: Christine Whitman

Phone: +1-216-227-2438



Miami Jewish Health Systems, Miami, FL, U.S.

Contact person: Jose G. Macias

Phone: +1-305-514-8535



Asaf Harofe Hospital, Beer Yakov, Zrifin, Israel

Contact person: Liat Yahimovitch

Phone: +972-8-9779561



ATP Clinical Research, Costa Mesa, California, U.S.

Contact person: Bobby Shih

Phone: +1-714-277-4472



neuroAD is an investigational device currently not commercially available in the United States.
neuroAD is CE-cleared and commercially available for the treatment of mild to moderate Alzheimer’s Disease in Europe.

® August 3, 2017 Neuronix | All rights reserved.
a site by razgroup